Anticoagulants for atrial fibrillation with valvular heart disease differ in safety

A large retrospective study of patients diagnosed with atrial fibrillation (AF) and valvular heart disease (VHD) showed that apixaban treatment was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of intracranial or gastrointestinal bleeding than rivaroxaban treatment. Researchers reported these findings on Oct. 17, 2022 in the Annals of Internal Medicine As background, […]